Home
    Disclaimer

    O-PCP Stats & Data

    2-keto-pcp
    Psychoactive Class Dissociative
    Half-Life Unknown; user reports suggest parent compound may clear within ~12 h with an estimated functional t½ of ~3–6 h. Low data quality.

    Effect Profile

    Curated
    Dissociative 5.7

    Strong dissociative depth and motor impairment with moderate mania, low insight

    Dissociative Depth×3
    10
    Mania / Compulsion×1
    6
    Insight / Novel Thought×2
    3
    Motor / Sensory Impairment×1
    10

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Oral
    19-40 minutes
    48 minutes - 2.0 hours
    1-2 hours
    1-8 hours
    Insufflated
    10-19 minutes
    48 minutes - 2.0 hours
    1-2 hours
    1-8 hours
    Vaporized / Inhaled
    4-15 minutes
    48 minutes - 2.0 hours
    1-2 hours
    1-8 hours
    Rectal (Boofed)
    15-30 minutes
    48 minutes - 2.0 hours
    1-2 hours
    1-8 hours
    Intramuscular
    4-15 minutes
    48 minutes - 2.0 hours
    1-2 hours
    1-8 hours

    Community Effects

    TripSit
    Positive
    dissociation stimulation
    Negative
    mania confusion

    Tolerance & Pharmacokinetics

    drugs.wiki
    Half-Life
    Unknown; user reports suggest parent compound may clear within ~12 h with an estimated functional t½ of ~3–6 h. Low data quality.
    Addiction Potential
    Moderate — dissociatives can induce compulsive redosing and psychological dependence; O‑PCP appears moreish for some, especially when vaped or insufflated. Anecdotal only; avoid frequent use.

    Tolerance Decay

    Full tolerance 1d Half tolerance 2d Baseline ~7d

    Pattern inferred from dissociative class reports (e.g., ketamine/MXE): rapid acute tolerance after a single heavy session; partial decay over 2–4 days; near‑baseline after about a week. Data are anecdotal; individual variability is large.

    Cross-Tolerances

    ketamine
    60% ●○○
    other arylcyclohexylamines
    70% ●○○

    Harm Reduction

    drugs.wiki

    Nomenclature and chemistry: IsomerDesign/PIHKAL-info lists this compound under 2′-Oxo‑PCP with synonyms 2‑Keto‑PCP and the IUPAC name 2‑Phenyl‑2‑(piperidin‑1‑yl)cyclohexan‑1‑one; this is the same entity often sold as O‑PCP. Early public discussion threads (May–June 2025) on Bluelight and Reddit confirm recent market appearance and repeated advice to confirm identity by GC–MS/FT‑IR due to confusion with O‑PCPr or O‑PCE. Mislabelled dissociatives are a documented drug‑checking problem; don’t assume label accuracy. Effects appear dissociative with a shorter plateau than PCP and variable sedation; users warn of a ‘clear‑headed’ window at low doses that fosters redosing. Motor incoordination and analgesia increase accident risk; have a sober sitter, avoid heights/water, and do not drive until fully baseline the next day. Combining with alcohol/benzodiazepines or opioids substantially increases vomiting/aspiration and respiratory depression risk; if someone is unresponsive, place them in the recovery position and call emergency services. Tramadol should be avoided due to seizure and serotonin‑toxicity risk; other serotonergic mixes (MAOI/SSRI/SNRI) are of uncertain safety — best avoided until real data exist. Dissociatives can precipitate panic, derealisation, mania, and psychosis in susceptible individuals; screen your set/setting, keep doses low, and avoid if you have a psychosis or seizure history. For dosing precision, volumetric dosing (e.g., 10 mg/mL in PG or ethanol/water) reduces milligram‑scale error; start with 1–2 mg allergy tests separated by at least 24 h. For IM use, only inject fully dissolved, filtered, sterile solutions; non‑sterile injection risks abscesses and systemic infection. Frequent or high‑dose dissociative use is linked to tolerance and dependence; bladder toxicity is well‑documented for ketamine, but is uncharacterised for O‑PCP — still, watch for urinary symptoms and reduce frequency. Drug checking at a professional service (FT‑IR/GC–MS) is strongly recommended whenever possible; reagent kits alone cannot distinguish close analogues.

    ← Back to O-PCP